Form 4: HCA Healthcare SVP Exercises Stock Appreciation Rights

HCA Healthcare's SVP & Controller, Christopher F. Wyatt, exercised stock appreciation rights and disposed of shares for tax purposes.

Summary

• Christopher F. Wyatt, SVP & Controller of HCA Healthcare, Inc., engaged in transactions involving the company's common stock on February 5, 2026.
• Wyatt exercised 10,670 Stock Appreciation Rights (SARs) at an exercise price of $139.06 per share.
• Concurrently, 5,674 shares of common stock were disposed of at a price of $513.76 per share, typically for tax withholding related to the SAR exercise.
• Following these transactions, Wyatt beneficially owns 46,063 shares of HCA Healthcare common stock.
• The transactions were conducted under a Rule 10b5-1(c) plan, indicating a pre-arranged trading strategy.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a routine insider transaction where an executive exercised vested equity awards. The disposition of shares for tax purposes is standard practice and does not indicate a negative sentiment towards the company.

Positives

• The exercise of Stock Appreciation Rights indicates a significant gain for the insider, as the exercise price ($139.06) is substantially lower than the disposition price ($513.76).
• The transaction was executed under a Rule 10b5-1(c) plan, suggesting a pre-planned, non-discretionary transaction rather than a market-timing decision.

Negatives

• A portion of the shares (5,674) were disposed of, reducing the direct beneficial ownership, although this is a common practice for tax withholding upon the exercise of equity awards.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.

Industry Context

StockSavvy.ai notes that insider transactions, particularly those under Rule 10b5-1 plans, are common for executives managing their equity compensation. For HCA Healthcare, this transaction reflects a routine exercise of vested equity awards by a senior executive.

Comparison to Industry Standards

• This type of insider transaction (exercise of Stock Appreciation Rights and subsequent tax-related disposition) is standard practice across industries for executives managing their equity compensation.
• Companies like UnitedHealth Group (UNH) or CVS Health (CVS), also in the healthcare sector, frequently report similar Form 4 filings for their executives, indicating the routine nature of such equity award management.

Stakeholder Impact

• Shareholders: Minimal direct impact, as this is a routine insider transaction. It shows an executive monetizing vested compensation, which is a normal part of executive compensation structures.

Key Dates

Recommendation

This Form 4 filing details a routine insider transaction involving the exercise of stock appreciation rights and subsequent tax-related share disposition by a senior executive. Such transactions, especially when conducted under a Rule 10b5-1 plan, are typically pre-scheduled and do not reflect new discretionary investment decisions or significant changes in company fundamentals. Therefore, it provides no new information that would warrant a change in investment recommendation for HCA Healthcare.

Keywords

HCA Healthcare, HCA, Form 4, Insider Trading, Stock Appreciation Rights, SARs, Equity Compensation, Christopher F. Wyatt, SVP & Controller, Rule 10b5-1